Pharmarise Holdings Corporation (2796.T)
JPY 479.0
(0.0%)
JPY 479.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.64 Billion JPY | 15.5% |
| 2022 | 2.29 Billion JPY | -0.52% |
| 2021 | 2.3 Billion JPY | -11.02% |
| 2020 | 2.58 Billion JPY | -2.16% |
| 2019 | 2.64 Billion JPY | 25.01% |
| 2018 | 2.11 Billion JPY | 0.43% |
| 2017 | 2.1 Billion JPY | -5.81% |
| 2016 | 2.23 Billion JPY | 14.53% |
| 2015 | 1.95 Billion JPY | 72.36% |
| 2014 | 1.13 Billion JPY | 15.86% |
| 2013 | 977.65 Million JPY | -3.51% |
| 2012 | 1.01 Billion JPY | 18.53% |
| 2011 | 854.85 Million JPY | 2.3% |
| 2010 | 835.63 Million JPY | 9.1% |
| 2009 | 765.93 Million JPY | 5.25% |
| 2008 | 727.7 Million JPY | -21.71% |
| 2007 | 929.51 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 4.03 Billion JPY | 52.55% |
| 2023 Q4 | 2.64 Billion JPY | -20.55% |
| 2023 Q1 | 3.08 Billion JPY | 34.85% |
| 2023 FY | 2.64 Billion JPY | 15.5% |
| 2023 Q3 | 3.32 Billion JPY | 33.48% |
| 2023 Q2 | 2.49 Billion JPY | -19.24% |
| 2022 FY | 2.29 Billion JPY | -0.52% |
| 2022 Q2 | 2.51 Billion JPY | -17.39% |
| 2022 Q1 | 3.04 Billion JPY | 32.15% |
| 2022 Q3 | 3.12 Billion JPY | 24.15% |
| 2022 Q4 | 2.29 Billion JPY | -26.6% |
| 2021 Q4 | 2.3 Billion JPY | -33.18% |
| 2021 FY | 2.3 Billion JPY | -11.02% |
| 2021 Q3 | 3.44 Billion JPY | 21.99% |
| 2021 Q2 | 2.82 Billion JPY | -10.29% |
| 2021 Q1 | 3.14 Billion JPY | 21.69% |
| 2020 Q4 | 2.58 Billion JPY | -25.45% |
| 2020 FY | 2.58 Billion JPY | -2.16% |
| 2020 Q1 | 3.38 Billion JPY | 27.99% |
| 2020 Q2 | 2.95 Billion JPY | -12.83% |
| 2020 Q3 | 3.47 Billion JPY | 17.63% |
| 2019 Q4 | 2.64 Billion JPY | -5.84% |
| 2019 FY | 2.64 Billion JPY | 25.01% |
| 2019 Q3 | 2.8 Billion JPY | 23.86% |
| 2019 Q2 | 2.26 Billion JPY | -14.49% |
| 2019 Q1 | 2.65 Billion JPY | 25.34% |
| 2018 Q2 | 2.03 Billion JPY | -20.04% |
| 2018 Q4 | 2.11 Billion JPY | -10.0% |
| 2018 FY | 2.11 Billion JPY | 0.43% |
| 2018 Q1 | 2.54 Billion JPY | 20.61% |
| 2018 Q3 | 2.35 Billion JPY | 15.71% |
| 2017 Q2 | 2.22 Billion JPY | -16.99% |
| 2017 Q1 | 2.67 Billion JPY | 19.77% |
| 2017 FY | 2.1 Billion JPY | -5.81% |
| 2017 Q4 | 2.1 Billion JPY | -20.35% |
| 2017 Q3 | 2.64 Billion JPY | 18.94% |
| 2016 Q1 | 2.36 Billion JPY | 21.19% |
| 2016 FY | 2.23 Billion JPY | 14.53% |
| 2016 Q4 | 2.23 Billion JPY | -16.5% |
| 2016 Q3 | 2.67 Billion JPY | 33.17% |
| 2016 Q2 | 2.01 Billion JPY | -15.0% |
| 2015 Q4 | 1.95 Billion JPY | -21.0% |
| 2015 FY | 1.95 Billion JPY | 72.36% |
| 2015 Q1 | 1.6 Billion JPY | 41.41% |
| 2015 Q2 | 1.94 Billion JPY | 21.55% |
| 2015 Q3 | 2.47 Billion JPY | 26.93% |
| 2014 Q3 | 1.49 Billion JPY | 51.73% |
| 2014 FY | 1.13 Billion JPY | 15.86% |
| 2014 Q1 | 1.33 Billion JPY | 36.92% |
| 2014 Q2 | 982.06 Million JPY | -26.64% |
| 2014 Q4 | 1.13 Billion JPY | -23.98% |
| 2013 Q2 | 935.31 Million JPY | -23.45% |
| 2013 Q4 | 977.65 Million JPY | -23.09% |
| 2013 FY | 977.65 Million JPY | -3.51% |
| 2013 Q1 | 1.22 Billion JPY | 20.59% |
| 2013 Q3 | 1.27 Billion JPY | 35.91% |
| 2012 Q1 | 1.04 Billion JPY | 22.13% |
| 2012 Q2 | 1 Billion JPY | -3.81% |
| 2012 Q4 | 1.01 Billion JPY | -18.55% |
| 2012 Q3 | 1.24 Billion JPY | 23.88% |
| 2012 FY | 1.01 Billion JPY | 18.53% |
| 2011 Q2 | 812.85 Million JPY | -12.95% |
| 2011 Q1 | 933.82 Million JPY | 11.75% |
| 2011 Q4 | 854.85 Million JPY | -17.47% |
| 2011 FY | 854.85 Million JPY | 2.3% |
| 2011 Q3 | 1.03 Billion JPY | 27.42% |
| 2010 Q2 | 731.65 Million JPY | -19.65% |
| 2010 Q1 | 910.55 Million JPY | 18.88% |
| 2010 FY | 835.63 Million JPY | 9.1% |
| 2010 Q3 | 996.44 Million JPY | 36.19% |
| 2010 Q4 | 835.63 Million JPY | -16.14% |
| 2009 Q4 | 765.93 Million JPY | 0.0% |
| 2009 FY | 765.93 Million JPY | 5.25% |
| 2008 Q3 | 1.07 Billion JPY | 53.11% |
| 2008 Q2 | 703.43 Million JPY | 0.0% |
| 2008 Q4 | 727.7 Million JPY | -32.44% |
| 2008 FY | 727.7 Million JPY | -21.71% |
| 2007 FY | 929.51 Million JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| HEARTSEED INC | 136.61 Million JPY | -1836.169% |
| Cawachi Limited | 34.72 Billion JPY | 92.384% |
| Qol Holdings Co., Ltd. | 5.17 Billion JPY | 48.839% |
| MatsukiyoCocokara & Co. | 139.35 Billion JPY | 98.102% |
| Welcia Holdings Co., Ltd. | 137.09 Billion JPY | 98.071% |
| Create SD Holdings Co., Ltd. | 42.13 Billion JPY | 93.722% |
| NIHON CHOUZAI Co.,Ltd. | 38.08 Billion JPY | 93.056% |
| COSMOS Pharmaceutical Corporation | 86.17 Billion JPY | 96.931% |
| Tsuruha Holdings Inc. | 147.17 Billion JPY | 98.203% |
| Ohki Healthcare Holdings Co.,Ltd. | 23.89 Billion JPY | 88.928% |
| Satudora Holdings Co.,Ltd. | 10.65 Billion JPY | 75.181% |
| Kusuri No Aoki Holdings Co., Ltd. | 47.79 Billion JPY | 94.466% |
| Medical System Network Co., Ltd. | 5.53 Billion JPY | 52.248% |
| Shinnihonseiyaku Co., Ltd. | 2.09 Billion JPY | -26.495% |
| Sugi Holdings Co.,Ltd. | 83.67 Billion JPY | 96.839% |
| YAKUODO HOLDINGS Co., Ltd. | 24.5 Billion JPY | 89.207% |
| Astena Holdings Co., Ltd. | 10.79 Billion JPY | 75.5% |
| Genky DrugStores Co., Ltd. | 24.02 Billion JPY | 88.992% |
| Ain Holdings Inc. | 24.64 Billion JPY | 89.267% |
| Sundrug Co.,Ltd. | 91.29 Billion JPY | 97.103% |